Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

176.00
Delayed Data
As of Sep 17
 -1.55 / -0.87%
Today’s Change
151.80
Today|||52-Week Range
195.81
+6.21%
Year-to-Date

Today’s Trading

Previous close177.55
Today’s open173.02
Day’s range173.02 - 177.82
Volume1,165,874
Average volume (3 months)1,151,473
Market cap$44.9B
Data as of 4:00pm ET, 09/17/2019

Growth & Valuation

Earnings growth (last year)+677.36%
Earnings growth (this year)+12.58%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+22.51%
P/E ratio20.6
Price/Sales14.09
Price/Book10.05

Competitors

 Today’s
change
Today’s
% change
TAKTakeda Pharmaceutica...+0.07+0.40%
AGNAllergan+0.54+0.33%
ZTSZoetis Inc+2.78+2.32%
----
Data as of 6:30pm ET, 09/17/2019

Financials

Next reporting dateOctober 23, 2019
EPS forecast (this quarter)$1.13
Annual revenue (last year)$3.0B
Annual profit (last year)$2.1B
Net profit margin68.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
Chief Financial Officer &
Executive Vice President
Charles F. Wagner
Corporate headquarters
Boston, Massachusetts

Forecasts